Clinical Trial: Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Long COVID
Study Type: INTERVENTIONAL
Official Title: An Exploratory, Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of an Anti-SARS-CoV-2 Monoclonal Antibody and Response to Treatment in Individuals With Long COVID (outSMART-LC)
Brief Summary:
Persistent viral infection with viral reservoirs and detection of circulating spike protein after the initial acute illness is one potential pathogenic mechanism for Long COVID.This mechanism may be able to be targeted by SARS-CoV-2 monoclonal antibodies (mAbs).This trial will study the safety and efficacy of AER002 to treat individuals with Long COVID in an adult population.
Read more